{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:35:00Z","timestamp":1751376900999,"version":"3.38.0"},"reference-count":46,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:p> Over the past few years, the increase in infectious syphilis outbreaks in major urban centres and remote or rural locations in Canada, often affecting hard-to-reach patient populations, has renewed an interest and urgency in studying the use of point-of-care tests (POCTs) that can provide test results at the time and place of primary health care delivery, obviating the repeat visit necessary with traditional syphilis serology or molecular diagnostic tests. In 2015, the Canadian Public Health Laboratory Network released its first laboratory guideline for the use of POCTs in the diagnosis of syphilis in Canada. Although Canada has no licensed POCT, two POCTs (Syphilis Health Check and the DPP\u00ae HIV Syphilis System) have received US Food and Drug Administration (FDA) approval under premarket approval applications. Most syphilis POCTs detect antibodies to treponemal antigens, so their results cannot be used to differentiate between active and past infection. The only POCT that detects antibodies to both treponemal and non-treponemal antigens does not yet have Health Canada or FDA approval. In this updated guideline, the current landscape of POCTs for syphilis, with an emphasis on data from low-prevalence countries, is described. Individual operators should consider the questions of where, when, how, and why a POCT is used before its actual implementation. Training in the operation and interpretation, quality control, proficiency program, safety, and careful documentation of the process and results are especially important for the successful implementation of POCTs. <\/jats:p>","DOI":"10.3138\/jammi-2021-0021","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T17:25:18Z","timestamp":1648661118000},"page":"85-96","source":"Crossref","is-referenced-by-count":2,"title":["Canadian Public Health Laboratory Network guidelines for the use of point-of-care tests for <i>Treponema pallidum<\/i> in Canada"],"prefix":"10.3138","volume":"7","author":[{"given":"Prenilla","family":"Naidu","sequence":"first","affiliation":[{"name":"Provincial Laboratory for Public Health, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond SW","family":"Tsang","sequence":"additional","affiliation":[{"name":"Syphilis Diagnostic Unit, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"12","key":"r1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1089\/aid.2007.0020","volume":"23","author":"Plate DK","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"6","key":"r2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(13)70004-5","volume":"13","author":"Yansouni CP","year":"2013","journal-title":"Lancet Infect Dis."},{"issue":"1","key":"r3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12913-018-3844-9","volume":"19","author":"Young N","year":"2019","journal-title":"BMC Health Services Research"},{"volume-title":"Point-of-Care Testing Toolkit","year":"2015","author":"CAP Point-of-Care Testing Committee","key":"r4"},{"journal-title":"JCInsight","year":"2018","author":"Joint Commission International","key":"r5"},{"key":"r6","unstructured":"6. Australian Government, Department of Health. Definitions\u2014point-of-care testing. 2013. https:\/\/www1.health.gov.au\/internet\/publications\/publishing.nsf\/Content\/qupp-review~qupp-definitions (Accessed February 6, 2020)."},{"key":"r7","unstructured":"7. College of Medical Laboratory Technologists of Ontario. Point-of-care testing in Ontario. 2007. http:\/\/cmlto.com\/index.php?option=com_content&view=article&id=1369:point-of-care-testing&catid=115:about-lab-tests-main&Itemid=567 (Accessed February 6, 2020)."},{"key":"r8","unstructured":"8. Canadian Agency for Drugs and Technologies in Health Point-of-care testing: an environmental scan. 2017. https:\/\/www.cadth.ca\/point-care-testing-environmental-scan (Accessed February 6, 2020)."},{"issue":"4","key":"r9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/fampra\/cmx134","volume":"35","author":"Schols AMR","year":"2018","journal-title":"Family Practice"},{"issue":"2","key":"r10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.14745\/ccdr.v44i02a02","volume":"44","author":"Choudhri Y","year":"2018","journal-title":"Can Commun Dis Rep"},{"issue":"11","key":"r11","first-page":"302","volume":"45","author":"Public Health Agency of Canada","year":"2019","journal-title":"Can Commun Dis Report"},{"key":"r12","unstructured":"12. Government of Alberta, Alberta Health Services. Public health alert: outbreak: syphilis. 2019. https:\/\/www.albertahealthservices.ca\/assets\/info\/hp\/phys\/if-hp-phys-moh-ez-syphilis-outbreak.pdf (Accessed February 10, 2020)."},{"key":"r13","unstructured":"13. Government of Manitoba. Sexually transmitted and bloodborne infections (STBBI) in Manitoba. 2018. https:\/\/www.gov.mb.ca\/health\/publichealth\/cdc\/docs\/stbbi_poster.pdf (Accessed February 10, 2020)."},{"key":"r14","unstructured":"14. Government of Northwest Territories, Health and Social Services. Syphilis outbreak issued for NWT. 2019. https:\/\/www.hss.gov.nt.ca\/en\/newsroom\/syphilis-outbreak-issued-nwt (Accessed February 10, 2020)."},{"key":"r15","unstructured":"15. Canadian Press. Saskatchewan experiencing HIV cases, syphilis outbreaks, health authority says.\u201d Toronto Star, June 14, 2019. https:\/\/www.thestar.com\/news\/canada\/2019\/06\/14\/saskatchewan-experiencing-hiv-syphilis-outbreaks-health-authority-says.html (Accessed March 1, 2021)."},{"key":"r16","unstructured":"16. Saskatchewan Health Authority. HIV and syphilis in Northwest SK June 14, 2019. 2019. https:\/\/www.youtube.com\/watch?v=fQU76TRqoWQ (Accessed March 1, 2021)."},{"key":"r17","unstructured":"17. Syphilis outbreak reported in northwestern Ontario. CBC News, July 15, 2019. https:\/\/www.cbc.ca\/news\/canada\/thunder-bay\/northwestern-ontario-syphilis-outbreak-1.5210288 (Accessed March 1, 2021)."},{"issue":"4","key":"r18","first-page":"215","volume":"4","author":"Singh AE","year":"2019","journal-title":"J Assoc Med Microbiol Infect Dis Canada"},{"key":"r19","first-page":"29A","volume":"26","author":"Singh AE","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"r20","unstructured":"20. Murtagh MM. The point-of-care diagnostic landscape for sexually transmitted infections (STIs). Woodside (CA): Murtagh Group; 2018."},{"issue":"13","key":"r21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0956462414531405","volume":"25","author":"Perry M","year":"2014","journal-title":"Int J STD AIDS"},{"issue":"3","key":"r22","doi-asserted-by":"crossref","first-page":"e91504","DOI":"10.1371\/journal.pone.0091504","volume":"9","author":"Causer LM","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"r23","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1136\/sextrans-2016-053065","volume":"93","author":"Zorzi A","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"12","key":"r24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1177\/0956462413487328","volume":"24","author":"Guinard J","year":"2013","journal-title":"Int J STD AIDS"},{"issue":"7","key":"r25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/PAT.0000000000000334","volume":"47","author":"Skinner L","year":"2015","journal-title":"Pathology"},{"key":"r26","unstructured":"26. Caya C, Sehrir B, Morin V, Proulx J-F, Yansouni CP. Validation and field deployment of a rapid diagnostic test for syphilis in Arctic communities. Poster at ArcticNet Annual Scientific Meeting\u2014Arctic Change 2017. 2017 Dec 11\u201315; Quebec City, Quebec, Canada."},{"issue":"8","key":"r27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/OLQ.0000000000000161","volume":"41","author":"Castro R","year":"2014","journal-title":"STD"},{"issue":"3","key":"r28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/OLQ.0000000000000932","volume":"46","author":"Obafemi OA","year":"2019","journal-title":"STD"},{"key":"r29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.15585\/mmwr.mm6542a5","volume":"65","author":"Matthias J","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"r30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/cid\/civ243","volume":"61","author":"Causer LM","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"r31","first-page":"S3","volume":"93","author":"Gliddon HD","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"1","key":"r32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-3567-x","volume":"19","author":"Van Den Heuvel A","year":"2019","journal-title":"BMC Infect Dis"},{"key":"r33","doi-asserted-by":"crossref","first-page":"e112190","DOI":"10.1371\/journal.pone.0112190","volume":"9","author":"Hess KL","year":"2014","journal-title":"PLoS One"},{"key":"r34","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/JCM.02468-14","volume":"52","author":"Humphries RM","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"1","key":"r35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/ajlm.v5i1.433","volume":"5","author":"Kalou MB","year":"2016","journal-title":"Afr J Lab Med"},{"issue":"1","key":"r36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/0956462417717649","volume":"29","author":"Holden J","year":"2018","journal-title":"Int J STD AIDS"},{"volume-title":"Selection criteria for point-of-care testing devices; approved guideline","year":"2010","author":"Clinical and Laboratory Standards Institute","key":"r37"},{"issue":"2","key":"r38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1128\/JCM.03152-15","volume":"54","author":"Leon SR","year":"2016","journal-title":"J Clin Microbiol"},{"key":"r39","unstructured":"39. World Health Organization. WHO information note on the use of dual HIV\/syphilis rapid diagnostic tests (RDT). https:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/dual-hiv-syphilis-diagnostic-tests\/en\/ (Accessed February 10, 2020)."},{"issue":"3","key":"r40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/OLQ.0000000000000413","volume":"43","author":"Peterman TA","year":"2016","journal-title":"Sex Transm Dis"},{"issue":"5","key":"r41","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/sti.2006.024265","volume":"82","author":"Peeling RW","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"9","key":"r42","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2471\/BLT.16.187468","volume":"95","author":"Kosack CS","year":"2017","journal-title":"Bull World Health Organization"},{"key":"r43","unstructured":"43. Association of Public Health Laboratories. Consultation on laboratory diagnosis of syphilis. Meeting summary report. 2018. https:\/\/www.aphl.org\/aboutAPHL\/publications\/Documents\/ID-2018Aug-Syphilis-Meeting-Report.pdf (Accessed February 6, 2020)."},{"key":"r44","unstructured":"44. International Organization for Standardization. Medical laboratories\u2014 particular requirements for quality and competence. ISO15189. Geneva: International Organization for Standardization; 2003."},{"key":"r45","unstructured":"45. International Organization for Standardization. Point-of-care testing (POCT)\u2014requirements for quality and competency. ISO22870. Geneva: International Organization for Standardization; 2016."},{"key":"r46","unstructured":"46. Health Canada. Guidance document: how to complete the application for a new medical device licence\/medical device licence amendment for a private label medical device. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medical-devices\/application-information\/guidance-documents\/guidance-document-complete-application-new-medical-device-licence-amendment-private-label.html (Accessed February 10, 2020)."}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2021-0021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T14:59:59Z","timestamp":1741877999000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2021-0021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6,1]]}},"alternative-id":["10.3138\/jammi-2021-0021"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2021-0021","relation":{},"ISSN":["2371-0888","2371-0888"],"issn-type":[{"type":"print","value":"2371-0888"},{"type":"electronic","value":"2371-0888"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}